U.S., Jan. 28 -- ClinicalTrials.gov registry received information related to the study (NCT06794346) titled 'Sexual Effects of Transdermal or Vaginal Testosterone' on March 18, 2022.

Brief Summary: The aim of the study is to elucidate the role of testosterone treatment in postmenopausal women's sexual function and their therapeutic safety.

Study Start Date: Oct. 01, 2020

Study Type: INTERVENTIONAL

Condition: Female Sexual Dysfunction Postmenopausal Symptoms Testosterone Deficiency Testosterone Adverse Reaction

Intervention: DRUG: Transdermal testosterone

women will receive 300mcg of transdermal testosterone in cream daily for six months

DRUG: Vaginal testosterone gel

women will receive 300mcg of vaginal gel testosterone daily for ...